Stocks and Investing Stocks and Investing
Fri, November 5, 2021

Jason Butler Maintained (VRDN) at Buy with Decreased Target to $36 on, Nov 5th, 2021


Published on 2024-10-27 18:32:20 - WOPRAI, Jason Butler
  Print publication without navigation


Jason Butler of JMP Securities, Maintained "Viridian Therapeutics, Inc." (VRDN) at Buy with Decreased Target from $44 to $36 on, Nov 5th, 2021.

Jason has made no other calls on VRDN in the last 4 months.



There is 1 other peer that has a rating on VRDN. Out of the 1 peers that are also analyzing VRDN, 0 agree with Jason's Rating of Hold.



This is the rating of the analyst that currently disagrees with Jason


  • Maneka Mirchandaney of "Evercore ISI Group" Initiated at Buy and Held Target at $40 on, Tuesday, October 12th, 2021
Contributing Sources